Elicio Therapeutics, Inc. · NASDAQ:ELTX

Knoll Capital Management, LLC reported a 5.30% stake in Elicio Therapeutics, Inc. (Schedule 13G/A)

Event Jul 1, 2026 · Filed Jul 8, 2026

Knoll Capital Management, LLC reported a 5.30% stake in Elicio Therapeutics, Inc., 1,211,957 shares, as a passive investor on Jul 1, 2026. Filed Jul 8, 2026 (Schedule 13G/A).

Stake
5.30%
Shares
1,211,957
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Knoll Capital Management, LLC5.30%1,211,957
Fred Knoll5.30%1,211,957
Gakasa Holdings, LLC5.30%1,211,957

Source

View original at SEC

Related